Suppr超能文献

从分子动力学模拟和结合自由能计算的角度理解抗体 VRC01 广谱而强效中和 HIV-1 的分子机制。

Understanding the molecular mechanism of the broad and potent neutralization of HIV-1 by antibody VRC01 from the perspective of molecular dynamics simulation and binding free energy calculations.

机构信息

School of Pharmacy, Lanzhou University, Lanzhou, 730000, China.

出版信息

J Mol Model. 2012 Sep;18(9):4517-27. doi: 10.1007/s00894-012-1450-z. Epub 2012 May 29.

Abstract

VRC01 is one of the most broadly and potently neutralizing HIV-1 antibodies known-it has been shown to neutralize 91 % of the tested primary isolate Env pseudoviruses by recognizing the viral envelope glycoprotein gp120. To explore the mechanism of HIV-1 neutralization by VRC01 and thus obtain valuable information for vaccine design, we performed molecular dynamics simulations and binding free energy calculations for apo-VRC01, apo-gp120, and the gp120-VRC01 complex. For gp120, residue energy decomposition analysis showed that the hotspot residues Asn280, Lys282, Asp368, Ile371, and Asp457 are located in three primary loops, including the CD4-binding loop, loop D, and loop V5. For VRC01, the hotspot residues Trp47, Trp50, Asn58, Arg61, Gln64, Trp100, and Tyr91 mainly come from CDR2 of the heavy chain. By decomposing the binding free energy into different components, intermolecular van der Waals interactions and nonpolar solvation were found to dominate the binding process. Principal component analysis of loops D and V5, which are related to neutralization resistance, indicated that these two areas have a larger conformational space in apo-gp120 compared to bound gp120. A comparison of three representative structures from the cluster analysis of loops D and V5 indicated that changes primarily occur at the tip of loop V5, and are caused by fluctuations in the terminal Glu1 residue of the antibody. This information can be used to guide the design of vaccines and small molecule inhibitors.

摘要

VRC01 是目前所知最广谱和高效中和 HIV-1 的抗体之一,它通过识别病毒包膜糖蛋白 gp120,已被证明能中和 91%的测试原发性分离物包膜假病毒。为了探索 VRC01 中和 HIV-1 的机制,从而为疫苗设计获取有价值的信息,我们对无配体的 VRC01、无配体的 gp120 以及 gp120-VRC01 复合物进行了分子动力学模拟和结合自由能计算。对于 gp120,残基能量分解分析表明,热点残基 Asn280、Lys282、Asp368、Ile371 和 Asp457 位于三个主要环中,包括 CD4 结合环、环 D 和环 V5。对于 VRC01,热点残基 Trp47、Trp50、Asn58、Arg61、Gln64、Trp100 和 Tyr91 主要来自重链的 CDR2。通过将结合自由能分解为不同的组成部分,发现分子间范德华相互作用和非极性溶剂化作用主导了结合过程。与中和耐药性相关的环 D 和 V5 的主成分分析表明,与结合的 gp120 相比,apo-gp120 中这两个区域具有更大的构象空间。对环 D 和 V5 的聚类分析中三个代表性结构的比较表明,主要变化发生在环 V5 的尖端,这是由抗体末端 Glu1 残基的波动引起的。这些信息可用于指导疫苗和小分子抑制剂的设计。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验